Soraya Carrancio

1.4k total citations
33 papers, 1.0k citations indexed

About

Soraya Carrancio is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Soraya Carrancio has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Genetics and 11 papers in Hematology. Recurrent topics in Soraya Carrancio's work include Protein Degradation and Inhibitors (11 papers), Mesenchymal stem cell research (9 papers) and Lymphoma Diagnosis and Treatment (7 papers). Soraya Carrancio is often cited by papers focused on Protein Degradation and Inhibitors (11 papers), Mesenchymal stem cell research (9 papers) and Lymphoma Diagnosis and Treatment (7 papers). Soraya Carrancio collaborates with scholars based in Spain, United States and France. Soraya Carrancio's co-authors include Jesús F. San Miguel, Fermín Sánchez‐Guijo, Juan F. Blanco, Sandra Muntión, Carlos Santamaría, Jesús G. Briñón, Belén Blanco, Pilar Hernández-Campo, M.C. del Cañizo and Natalia López-Holgado and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Soraya Carrancio

31 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Soraya Carrancio Spain	15	386	380	298	200	175	33	1.0k
Eva M. Villarón Spain	13	364 0.9×	597 1.6×	232 0.8×	53 0.3×	240 1.4×	23	1.1k
Luciana Vinti Italy	15	248 0.6×	274 0.7×	219 0.7×	110 0.6×	87 0.5×	59	781
David D.F. Australia	14	138 0.4×	193 0.5×	213 0.7×	106 0.5×	147 0.8×	17	645
Matjaž Sever Slovenia	15	136 0.4×	365 1.0×	373 1.3×	57 0.3×	430 2.5×	52	984
Alessandra Marrelli Italy	16	68 0.2×	198 0.5×	362 1.2×	398 2.0×	202 1.2×	23	1.2k
Camillo Almici Italy	19	502 1.3×	248 0.7×	314 1.1×	67 0.3×	92 0.5×	72	1.1k
Ana Henriques Portugal	18	75 0.2×	393 1.0×	219 0.7×	190 0.9×	90 0.5×	40	1.1k
Baijun Fang China	17	296 0.8×	710 1.9×	334 1.1×	31 0.2×	403 2.3×	42	1.1k
Brigitta Omazic Sweden	13	585 1.5×	773 2.0×	258 0.9×	105 0.5×	357 2.0×	19	1.5k
Giulio Bassi Italy	13	130 0.3×	507 1.3×	525 1.8×	34 0.2×	203 1.2×	23	1.0k

Countries citing papers authored by Soraya Carrancio

Since Specialization

Citations

This map shows the geographic impact of Soraya Carrancio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soraya Carrancio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soraya Carrancio more than expected).

Fields of papers citing papers by Soraya Carrancio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soraya Carrancio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soraya Carrancio. The network helps show where Soraya Carrancio may publish in the future.

Co-authorship network of co-authors of Soraya Carrancio

This figure shows the co-authorship network connecting the top 25 collaborators of Soraya Carrancio. A scholar is included among the top collaborators of Soraya Carrancio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soraya Carrancio. Soraya Carrancio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bachy, Emmanuel, Jean‐Marie Michot, Judit Jørgensen, et al.. (2025). ABCL-1115: Golcadomide, a Cereblon E3 Ligase Modulator (CELMoD) Agent, With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Updated Phase 1/2 Results. Clinical Lymphoma Myeloma & Leukemia. 25. S781–S782.

Michot, Jean‐Marie, Franck Morschhauser, Silvia Martina Ferrari, et al.. (2024). Longer Follow-up of Golcadomide (GOLCA), a Cereblon E3 Ligase Modulator (CELMoD™) Agent ± Rituximab (RTX), in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). Blood. 144(Supplement 1). 869–869. 1 indexed citations

Michot, Jean‐Marie, Julio C. Chávez, Cecilia Carpio, et al.. (2023). OPEN‐LABEL PHASE 1/2 STUDY OF CC‐99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL). Hematological Oncology. 41(S2). 134–136.

Abbiati, R., Michael Pourdehnad, Soraya Carrancio, et al.. (2021). Quantitative Systems Pharmacology Modeling of Avadomide-Induced Neutropenia Enables Virtual Clinical Dose and Schedule Finding Studies. The AAPS Journal. 23(5). 3 indexed citations

Carrancio, Soraya, Lynda Groocock, Ryan Galasso, et al.. (2021). CC-99282 is a Novel Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Agent with Enhanced Tumoricidal Activity in Preclinical Models of Lymphoma. Blood. 138(Supplement 1). 1200–1200. 12 indexed citations

Lopez‐Girona, Antonia, Lynda Groocock, Zhongying Mo, et al.. (2021). CC‐99282 IS A NOVEL CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT WITH POTENT AND BROAD ANTITUMOR ACTIVITY IN PRECLINICAL MODELS OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). Hematological Oncology. 39(S2). 4 indexed citations

Michot, Jean‐Marie, Julio C. Chávez, Cecilia Carpio, et al.. (2021). Clinical Activity of CC-99282, a Novel, Oral Small Molecule Cereblon E3 Ligase Modulator (CELMoD) Agent, in Patients (Pts) with Relapsed or Refractory Non-Hodgkin Lymphoma (R/R NHL) - First Results from a Phase 1, Open-Label Study. Blood. 138(Supplement 1). 3574–3574. 13 indexed citations

Romero, Juan P., Soraya Carrancio, Fernando J. de Miguel, et al.. (2018). Comparison of RNA-seq and microarray platforms for splice event detection using a cross-platform algorithm. BMC Genomics. 19(1). 703–703. 17 indexed citations

Sánchez‐Abarca, Luis Ignacio, Carmen Herrero, Almudena Velasco, et al.. (2015). Human Bone Marrow Stromal Cells Differentiate into Corneal Tissue and Prevent Ocular Graft-Versus-Host Disease in Mice. Cell Transplantation. 24(12). 2423–2433. 14 indexed citations

10.

Rica, Lorenzo de la, Esteban Ballestar, Carlos Santamaría, et al.. (2012). Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment. Leukemia Research. 36(7). 895–899. 13 indexed citations

11.

Santamaría, Carlos, Sandra Muntión, Beatriz Rosón, et al.. (2012). Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients. Haematologica. 97(8). 1218–1224. 86 indexed citations

12.

Muntión, Sandra, Fermín Sánchez‐Guijo, Soraya Carrancio, et al.. (2012). Optimisation of mesenchymal stromal cells karyotyping analysis: implications for clinical use. Transfusion Medicine. 22(2). 122–127. 12 indexed citations

13.

Caballero‐Velázquez, Teresa, Luís I. Sánchez-Abarca, Belén Blanco, et al.. (2012). The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation. Haematologica. 97(9). 1329–1337. 14 indexed citations

14.

Carrancio, Soraya, Jennifer A. Markovics, Piu Wong, et al.. (2012). Sotatercept, an Activin Receptor IIa Ligand Trap, Acts Through Bone Marrow Accessory Cells to Promote Late-Stage Erythropoiesis and a Rapid Induction of Red Blood Cell Number and Hemoglobin. Blood. 120(21). 372–372. 1 indexed citations

15.

Carrancio, Soraya, Belén Blanco, Carlos G. Romo, et al.. (2011). Bone Marrow Mesenchymal Stem Cells for Improving Hematopoietic Function: An In Vitro and In Vivo Model. Part 2: Effect on Bone Marrow Microenvironment. PLoS ONE. 6(10). e26241–e26241. 38 indexed citations

16.

Blanco, Juan F., Fermín Sánchez‐Guijo, Soraya Carrancio, et al.. (2011). Titanium and tantalum as mesenchymal stem cell scaffolds for spinal fusion: an in vitro comparative study. European Spine Journal. 20(S3). 353–360. 30 indexed citations

17.

Pérez-Simón, Josè Antonio, Teresa Caballero‐Velázquez, Teresa Flores, et al.. (2010). Limbus Damage in Ocular Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 17(2). 270–273. 26 indexed citations

18.

Blanco, Juan F., Ignacio de la Fuente, Fermín Sánchez‐Guijo, et al.. (2010). Isolation and Characterization of Mesenchymal Stromal Cells From Human Degenerated Nucleus Pulposus. Spine. 35(26). 2259–2265. 170 indexed citations

19.

Sánchez‐Guijo, Fermín, Juan F. Blanco, Sandra Muntión, et al.. (2009). Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects. Cell and Tissue Research. 336(3). 501–507. 25 indexed citations

20.

Carrancio, Soraya, Natalia López-Holgado, Fermín Sánchez‐Guijo, et al.. (2008). Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Experimental Hematology. 36(8). 1014–1021. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact